Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: ALL

Chairs: Jeffrey J. Teuteberg, MD and Lara Danziger-Isakov, MD, MPH
 

8:00 AM	Welcome/Program Chair Report Lara Danziger-Isakov, MD, MPH, Children's Hospital Medical Center, Cincinnati, OH, USA
8:10 AM	Thoracic Registry Report Josef Stehlik, MD, MPH, University of Utah School of Medicine, Salt Lake City, UT, USA
8:20 AM	IMACS Registry Report Daniel J. Goldstein, MD, Montefiore Medical Center, Bronx, NY, USA
8:30 AM	Journal Editor's Report Mandeep R. Mehra, MD, FRCP, FACC, FESC. Brigham and Women's Hospital, Boston, MA, USA
8:40 AM	President's Report Jeffrey J. Teuteberg, MD, Stanford University School of Medicine, Stanford, CA, USA
8:55 AM	(1) Clinical Outcomes by Intended Goal of Therapy in the MOMENTUM 3 Clinical Trial: Final Analysis of the 1028 Patient Full Cohort D. Goldstein1, M. R. Mehra2, MOMENTUM 3 Investigators2. 1Dept of Cardiothoracic Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, 2Brigham and Women's Hospital, Boston, MA
9:10 AM	Expert Interactive Discussant for Clinical Outcomes by Intended Goal of Therapy in the MOMENTUM 3 Clinical Trial: Final Analysis of the 1028 Patient Full Cohort Robert Kormos, MD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
9:15 AM	(2) INSPIRE: A Phase 3 Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension (PAH) (Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil NCT03399604) N. S. Hill1, J. P. Feldman2, S. Sahay3, D. J. Levine4, R. F. Roscigno5, T. A. Vaughn5, T. M. Bull6. 1Tufts Medical Center, Boston, MA, 2Arizona Pulmonary Specialists, Ltd, Phoenix, AZ, 3Weill Cornell Medicine, Institute of Academic Medicine, Houston Methodist Lung Center, Houston Methodist, Houston, TX, 4University of Texas Health Sciences Center at San Antonio, San Antonio, TX, 5Liquidia Technologies, Morrisville, NC, 6Anschutz Medical Campus, University of Colorado Denver, Aurora, CO
8:55 AM	Expert Interactive Discussant for INSPIRE: A Phase 3 Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension (PAH) (Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil NCT03399604) Jean-Luc Vachiery, MD, Erasme University Hospital, Brussels, Belgium
9:35 PM	Lifetime Achievement Award Recipient Lecture John Wallwork, FRCS, Papworth Hospital, Cambridge, UK

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: HF/HTX
Secondary Audience: EEP, ID, PATH

Chairs: Are M. Holm, MD, PhD, Howard Eisen, MD and Victor Rossel, MD
 

12:45 PM	(33) Sequential Measurement of Trypanosoma cruzi Parasitic Load in Endomyocardial Biopsies for Early Detection and Follow-up of Chagas Disease Reactivation After Heart Transplantation L. A. Benvenuti1, A. Roggério1, A. S. Nishiya2, S. Mangini1, J. E. Levi2. 1Heart Institute (InCor), Hospital das Clínicas da FMUSP, São Paulo, Brazil, 2Fundação Pró-Sangue, Hospital das Clínicas da FMUSP, São Paulo, Brazil
12:57 PM	(34) The Paradigm of Gender: Mismatch and Its Influence on Short and Long-Term Outcomes after Heart Transplantation M. D. Gilbert1, P. A. Morejón2, M. F. Renedo2, E. F. Giordanino2, L. E. Favaloro2, R. D. Ratto2, D. O. Absi1, R. R. Favaloro1, A. M. Bertolotti1. 1Cardiovascular, Thoracic Surgery, and Intrathoracic Transplantation, Hospital Universitario Fundación Favaloro, Buenos Aires, Argentina, 2Heart Failure and Heart Transplantation, Hospital Universitario Fundación Favaloro, Buenos Aires, Argentina
1:09 PM	(35) Incidence of Right Ventricular Dysfunction in Adult Patients Submitted to Heart Transplantation According to the Presence of Pre-Transplant Pulmonary Hypertension M. M. Lensi, A. S. Ramos, J. Xavier Junior, L. B. Seguro, S. Mangini, M. S. Ávila, I. W. Campos, A. P. Duque, F. Gaiotto, S. P. Steffen, F. Bacal, F. G. Marcondes-Braga. Heart Transplant Department, Heart Institute - InCor HC FMUSP, São Paulo, Brazil
1:21 PM	(36) The Effect of Donor-Recipient Heart Mass and Size Matching in Primary Graft Dysfunction Development after Heart Transplantation M. D. Gilbert1, P. A. Morejón2, M. F. Renedo2, E. F. Giordanino2, L. E. Favaloro2, R. D. Ratto2, D. O. Absi1, R. R. Favaloro1, A. M. Bertolotti1. 1Cardiovascular, Thoracic Surgery, and Intrathoracic Transplantation, Hospital Universitario Fundación Favaloro, Buenos Aires, Argentina, 2Heart Failure and Heart Transplantation, Hospital Universitario Fundación Favaloro, Buenos Aires, Argentina
1:33 PM	(37) Endomyocardial Biopsy after Heart Transplantation. When is Too Late? L. M. Guerrero Cepeda, F. G. Marcondes-Braga, D. M. Costa, R. M. Mendes, S. Duarte, J. C. Oliveira, I. Wosniack, L. F. Seguro, S. Mangini, F. Gaiotto, R. H. Santos, M. S. Avila, F. Bacal. Heart Transplantion, Instituto do Coração INCOR, São Paulo, Brazil

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: ALL

Chairs: Ryan Butts, MD and Lavanya Bellumkonda, MD
 

4:15 PM	(66) Stop the Leak! Transcatheter Aortic Valve Replacement in Pediatric VAD Patient H. P. Tunuguntla1, I. Adachi2, A. Khan1, B. A. Elias2, S. Choudhry1, A. G. Cabrera1, J. F. Price1, W. J. Dreyer1, S. W. Denfield1, J. A. Spinner1, A. Jeewa3, A. M. Qureshi1. 1Pediatric Cardiology, Texas Children's Hospital, Houston, TX, 2Congenital Heart Surgery, Texas Children's Hospital, Houston, TX, 3Pediatric Cardiology, The Hospital for Sick Children, Toronto, ON, Canada
4:20 PM	Expert Discussant for Stop the Leak! Transcatheter Aortic Valve Replacement in Pediatric VAD Patient Christopher Almond, MD, Stanford University, Stanford, CA, USA
4:25 PM	Discussion
4:32 PM	(67) The Utility of CardioMEMS Implantable Hemodynamic Monitoring Device in Heartware HVAD Patient with Recurrent Gastrointestinal Bleeding H. Singh1, V. Kittipibul2, R. Flowers2, S. V. Chaparro3. 1University of Miami Miller School of Medicine, Miami, FL, 2Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, 3Cardiovascular Medicine Division, University of Miami Miller School of Medicine, Miami, FL
4:37 PM	Expert Discussant for The Utility of CardioMEMS Implantable Hemodynamic Monitoring Device in Heartware HVAD Patient with Recurrent Gastrointestinal Bleeding Robert L. Kormos, MD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
4:42 PM	Discussion
4:49 PM	(68) Inverted Lung Transplantation: Interposition of Pericardial Conduit for Pulmonary Venous Anastomosis H. Yamamoto1, K. Miyoshi2, T. Kurosaki1, S. Otani1, M. Okazaki1, S. Sugimoto1, M. Yamane1, S. Toyooka1, T. Oto1. 1General Thoracic Surgery, Organ Transplant Center, Okayama University Hospital, Okayama, Japan, 2General Thoracic Surgery, Okayama Medical Center, Okayama, Japan
4:54 PM	Expert Discussant for Inverted Lung Transplantation: Interposition of Pericardial Conduit for Pulmonary Venous Anastomosis Christopher H. Wigfield, MD, FRCS, Advocate Christ Medical Center, Chicago, IL, USA
4:59 PM	Discussion
5:06 PM	(69) Successful Bacteriophage Therapy for Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infection in a Cystic Fibrosis Patient N. Law1, C. Logan1, C. Furr2, S. Lehman2, S. Morales2, F. Rosas2, A. Gaidamaka2, I. Bilinsky2, P. Grint2, R. Schooley1, S. Aslam1. 1University of California, San Diego, San Diego, CA, 2AmpliPhi Biosciences Inc, San Diego, CA
5:11 PM	Expert Discussant for Successful Bacteriophage Therapy for Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infection in a Cystic Fibrosis Patient Nicolas Mueller, MD, University Hospital Zurich, Zurich, Switzerland
5:16 PM	Discussion
5:23 PM	(70) Tocilizumab for Antibody-Mediated Rejection in the Setting of Cardiac Allograft Vasculopathy S. January1, A. Pottebaum1, D. Raymer1, K. Lavine2. 1Barnes-Jewish Hospital, St Louis, MO, 2Washington University School of Medicine, St Louis, MO
5:28 PM	Expert Discussant for Tocilizumab for Antibody-Mediated Rejection in the Setting of Cardiac Allograft Vasculopathy Jon A. Kobashigawa, MD, Cedars-Sinai Heart Institute, Los Angeles, CA, USA
5:33 PM	Discussion
5:40 PM	(71) Expanding Benefits from Cardiac Resynchronization Therapy to Exercise-Induced Left Bundle Branch Block in the Setting of Advanced Heart Failure: A Case Report F. L. Scolari, W. R. Menegazzo, A. D. Silveira, A. C. Mendes, M. Pimentel, N. Clausell, L. Goldraich. Hospital de Clínicas Porto Alegre, Porto Alegre, Brazil
5:45 PM	Expert Discussant for Expanding Benefits from Cardiac Resynchronization Therapy to Exercise-Induced Left Bundle Branch Block in the Setting of Advanced Heart Failure: A Case Report Sharon A. Hunt, MD, Stanford University Medical Center, Stanford, CA, USA
5:50 PM	Discussion

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: HF/HTX
Secondary Audiences: ID, LF/LTX, MCS, PEDS, PH

Session Summary: This symposium will highlight the most exciting publications in JHLT over the past year, each paper followed by a discussion by one of the senior editorial consultants of the journal to relate the presented articles to the greater body of published literature and discuss how they advance our understanding in the field.

Chairs: Manreet Kanwar, MD and Martin Schweiger, PhD, MD
 

1:45 PM	JHLT Best Papers of 2018 Patricia A. Uber, PharmD, Virginia Commonwealth University, Richmond, VA, USA
1:50 PM	Highlights of Heart Transplantation and MCS Simon Pecha, MD, University Hospital Hamburg, Hamburg, Germany
2:05 PM	Invited Discussant in Heart Transplantation and MCS Francis D. Pagani, MD, PhD, University of Michigan, Ann Arbor, MI, USA
2:15 PM	Highlights of Lung Transplantation and Pulmonary Hypertension Peter Riddell, MBBS, Mater Misericordiae University Hospital, Dublin, Ireland
2:30 PM	Invited Discussant in Lung Transplantation and Pulmonary Hypertension Jason D. Christie, MD, University of Pennsylvania, Philadelphia, PA, USA
2:40 PM	Highlights of Pediatric Heart and Lung Transplantation Ann R. Punnoose, MD, Children's Hospital of Wisconsin, Milwaukee, WI, USA
2:55 PM	Invited Discussant in Pediatric Heart and Lung Transplantation Stuart C. Sweet, MD, PhD, St. Louis Children's Hospital, St. Louis, MO, USA
3:05 PM	Highlights of Infectious Disease Jonathan M. Hand, MD, Ochsner Medical Center, New Orleans, LA, USA
2:15 PM	Invited Discussant in Infectious Diseases Emily A. Blumberg, MD, University of Pennsylvania, Philadelphia, PA, USA

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: ALL

Chairs: Hermann Reichenspurner, MD, PhD and Christopher H. Wigfield, MD, FRCS
 

4:00 PM	(182) B Cells Drive Chronic Lung Allograft Rejection after Ischemia-Reperfusion Injury in Mouse Lung Transplantation T. Watanabe, T. Martinu, K. Boonstra, M. Horie, Z. Guan, B. Joe, K. Bei, A. Chruscinski, D. Hwang, M. Liu, S. Keshavjee, S. Juvet. University Health Network, Toronto, ON, Canada
4:15 PM	(183) Microbiome Dependent Regulatory T Cell Generation Correlates with Acute and Chronic Lung Allograft Rejection in a Murine Model Y. Guo1, Q. Wang1, D. Li1, A. Manafi1, Z. Mei1, O. Onyema1, A. E. Gelman2, D. Kreisel2, A. S. Krupnick1. 1Surgery, University of Virginia, Charlottesville, VA, 2Surgery, Washington University in St. Louis, St. Louis, MO
4:30 PM	(184) Right Ventricular Dysfunction Correlates with Decreased Endothelial Progenitor Cell Mobilisation and Impaired Angiogenesis in Patients with Dilated Cardiomyopathy S. Frljak1, M. Jaklic1, G. Zemljic1, A. Cerar1, G. Poglajen1, F. Haddad2, B. Vrtovec1. 1Advanced Heart Failure and Transplantation Center, UMC Ljubljana, Ljubljana, Slovenia, 2Stanford Cardiovascular Institute, Stanford, CA
4:45 PM	(185) Host miRNA Profile of Invasive Aspergillosis in Lung Transplant Recipients W. Gohir1, W. Klement2, L. G. Singer3, S. M. Palmer4, S. Keshavjee3, S. Husain1. 1Multi Organ Transplant Unit, Division of Infectious Diseases, University Health Network, Toronto, ON, Canada, 2Organ Donation and Transplantation, Canadian Blood Services, Ottawa, ON, Canada, 3Toronto Lung Transplant Program, University Health Network, Toronto, ON, Canada, 4Division of Pulmonary and Critical Care Medicine, Duke University, Durham, NC
5:00 PM	(186) Estimation of Pulmonary Capillary Wedge Pressure from the HVAD Waveform and Its Prognostic Implications T. Imamura, D. Nitta, D. Rodgers, J. Grinstein, S. Kalantari, B. Smith, J. Raikhelkar, G. Kim, A. Nguyen, N. Narang, B. Chung, I. Ebong, L. Holzhauser, T. Fujino, C. Juricek, P. Combs, T. Song, T. Ota, V. Jeevanandam, G. Sayer, N. Uriel. University of Chicago, Chicago, IL
5:15 PM	(187) Hemodynamic Parameters That Predict Success with an Ambulatory Counterpulsation Heart Assist System in Advanced Congestive Heart Failure T. Symalla1, T. Song1, D. Onsager1, T. Ota1, C. LaBuhn1, P. Combs1, T. Lammy1, S. Patel-Raman2, G. Sayer3, G. Kim3, J. Raikhelkar3, N. Uriel3, V. Jeevanandam1. 1Cardiac Surgery, University of Chicago, Chicago, IL, 2NuPulseCV, NuPulseCV, Chicago, IL, 3Cardiology, University of Chicago, Chicago, IL
5:30 PM	(188) A Novel Tool to Quantify Immune Suppression after Pediatric Transplantation: Flow Cytometric Activation Assays R. E. Penner1, L. Ionescu1, S. Mital2, B. Foster3, P. Birk4, V. Phan5, T. Blydt-Hansen6, U. Allen2, L. Hamiwka7, C. Morgan1, S. Urschel1. 1University of Alberta, Edmonton, AB, Canada, 2Hospital for Sick Children, Toronto, ON, Canada, 3McGill University, Montreal, QC, Canada, 4University of Manitoba, Winnipeg, MB, Canada, 5CHU Sainte-Justine, Montreal, QC, Canada, 6BC Children's Hospital, Vancouver, BC, Canada, 7Alberta Children's Hospital, Calgary, AB, Canada

Visit the ISHLT2019 Online Program Viewer to see the full abstracts from this session

Primary Audience: ALL

Chairs: David O. Taylor, MD and Lori J. West, MD, DPhil
 

8:00 AM	New Perspectives on Tolerance Sing Sing Way, MD, PhD, Cincinnati Children’s Hospital, Cincinnati, OH, USA
8:20 AM	(3) Safety and Efficacy of Bacteriophage Therapy in Lung Transplant Candidates and Recipients A. Courtwright1, C. Koval2, S. Lehman3, S. Morales3, C. L. Furr3, F. Rosas3, M. Brownstein4, J. Fackler4, B. M. Sisson4, B. Biswas5, R. T. Schooley6, S. Aslam6. 1Pulmonary and Critical Care Medicine, University of Pennsylvania, Philadelphia, PA, 2Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, OH, 3AmpliPhi Biosciences, San Diego, CA, 4Adaptive Phage Therapeutics, Gaithersburg, MD, 5Naval Medical Research Center, Fort Detrick, MD, 6Department of Infectious Diseases, UC San Diego, San Diego, CA
8:35 AM	Expert Interactive Discussant for Safety and Efficacy of Bacteriophage Therapy in Lung Transplant Candidates and Recipients Fernanda Silveira, MD, University of Pittsburgh, Pittsburgh, PA, USA
8:40 AM	(4) Increased Volume, Improved Quality, and Better Outcomes Using a Specialized Thoracic Adapted Recovery (STAR) Model for Thoracic Transplantation: Experience from 1000 Cases H. Tetteh1, P. Brandenhoff2, R. S. Higgins3. 1Department of Surgery, Uniformed Services University, Bethesda, MD, 2Cardiothoracic Surgery, Thoracic Transplant Consultants, San Francisco, CA, 3Department of Surgery, Johns Hopkins University, Baltimore, MD
8:55 AM	Expert Interactive Discussant for Increased Volume, Improved Quality, and Better Outcomes Using a Specialized Thoracic Adapted Recovery (STAR) Model for Thoracic Transplantation: Experience from 1000 Cases Andreas Zuckermann, MD, Medical University of Vienna, Vienna, Austria
9:00 AM	Transplant from Every Angle Susan Hou, MD, Loyola University Medical Center, Maywood, IL, USA
9:20 AM	Countdown to Teamwork Colonel Mike Mullane, Astronaut, Albuquerque, NM, USA

Visit the ISHLT2019 Online Program Viewer to see the full details for this session

Primary Audience: ALL

Chairs: Stuart Sweet, MD, PhD and Stephan M. Ensminger, MD, DPhil
 

8:00 AM	Awards Presentations Kathleen L. Grady, PhD, APN, FAAN, Northwestern Memorial Hospital, Chicago, IL, USA
8:30 AM	What's Hot, What's New: Basic Science Overview Stijn E. Verleden, PhD, KU Leuven, Leuven, Belgium
8:50 AM	What’s Hot, What’s New: Clinical Science Overview Maria Rosa Costanzo, MD, Midwest Heart Specialists-Advocate Medical, Naperville, IL, USA
9:10 AM	PRESIDENT'S DEBATE: Resource Limits: It’s Time to Abandon Retransplantation (PRO) Josef Stehlik, MD, MPH, University of Utah School of Medicine, Salt Lake City, UT, USA
9:30 AM	PRESIDENT'S DEBATE: Resource Limits: It’s Time to Abandon Retransplantation (CON) Andrew J. Fisher, FRCP, PhD, Newcastle University, Newcastle Upon Tyne, UK
9:10 AM	Debate Rebuttal (PRO) - Josef Stehlik, MD, MPH
9:30 AM	Debate Rebuttal (CON) - Andrew J. Fisher, FRCP, PhD